"Having an FDA-approved product would have helped increase public awareness of PTSD and driven interest in developing new therapies," said Lori Davis, highlighting the setback after the rejection of MDMA-AT.
"Despite the common belief that PTSD is intractable, it is a treatable condition," stated Paula P. Schnurr, emphasizing that effective treatments exist, although responses vary among patients.
Collection
[
|
...
]